AMYT
$9.55
Amryt Pharma Plc ADR
($.27)
(2.75%)
AMYT
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.13)
Revenue:  $58.70 Mil
Wednesday
Feb 2
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made
Latest EPS

What do you expect when AMYT reports earnings?
Beat
Meet
Miss

Where is AMYT's stock price going from here?
Up
Flat
Down
Stock chart of AMYT
Analysts
Summary of analysts' recommendations for AMYT
Score
Grade
Pivots
Resistance
$10.26
$10.03
$9.79

$9.56

Support
$9.32
$9.09
$8.85
Tweet
Growth
Description
Amryt Pharma plc is a biopharmaceutical company. It develops and commercializes therapeutics to treat rare diseases. Amryt Pharma plc is based in London, the United Kingdom.